SEC Stock Data Quick Answer Longevity Health Holdings, Inc. reported Shares Outstanding of 1.78 million shares for fiscal year 2025. Longevity Health Holdings, Inc. Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 1.78M +155.6% 2024 696,969 -97.0% 2023 23.09M +20.0% 2023 19.24M +2045.5% 2022 896,580 — Quarterly Shares Outstanding Quarter Ending Shares Outstanding YoY … Read more
Quick Answer Longevity Health Holdings, Inc. reported Gross Profit of $1.09 million for fiscal year 2025. Longevity Health Holdings, Inc. Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2025 $1.09M +2390.3% 2024 $44.0K — 2023 $0.00 — Quarterly Gross Profit Quarter Ending Gross Profit YoY QoQ September 30, 2025 $254.5K +1523.0% -15.9% … Read more
Quick Answer Longevity Health Holdings, Inc. reported Operating Income of -$7.11 million for fiscal year 2025. Longevity Health Holdings, Inc. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$7.11M -42.2% 2024 -$5.00M +15.9% 2023 -$5.94M -7.9% 2022 -$5.51M -1078.3% 2021 -$467.4K — Quarterly Operating Income Quarter Ending Operating Income YoY QoQ … Read more
Quick Answer Longevity Health Holdings, Inc. reported R&D Expense of $788.9 thousand for fiscal year 2025. Longevity Health Holdings, Inc. R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $788.9K -25.2% 2024 $1.05M -57.8% 2023 $2.50M +13.7% 2022 $2.20M — Quarterly R&D Expense Quarter Ending R&D Expense YoY QoQ September 30, 2025 … Read more
Quick Answer Longevity Health Holdings, Inc. reported Stockholders Equity of -$5.87 million for fiscal year 2025. Longevity Health Holdings, Inc. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 -$5.87M -24.5% 2024 -$4.71M -119.0% 2023 $24.75M +165.5% 2022 -$37.79M -27.8% 2021 -$29.58M — 2021 $0.00 — Quarterly Stockholders Equity Quarter Ending Stockholders … Read more
Quick Answer Longevity Health Holdings, Inc. reported Cash and Equivalents of $706.7 thousand for fiscal year 2025. Longevity Health Holdings, Inc. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $706.7K +349.8% 2024 $157.1K -79.7% 2021 $774.2K — 2021 $0.00 — Quarterly Cash and Equivalents Quarter Ending Cash and Equivalents … Read more
Quick Answer Longevity Health Holdings, Inc. reported Total Assets of $2.37 million for fiscal year 2025. Longevity Health Holdings, Inc. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $2.37M +60.6% 2024 $1.47M -97.7% 2023 $63.95M +3557.3% 2022 $1.75M -98.9% 2021 $155.42M — Quarterly Total Assets Quarter Ending Total Assets YoY QoQ … Read more
Quick Answer Longevity Health Holdings, Inc. reported Diluted EPS of $4.83 per share (loss) for fiscal year 2025. Longevity Health Holdings, Inc. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 -$4.83 +66.8% 2024 -$14.56 -897.3% 2023 -$1.46 +73.3% 2022 -$5.47 — Quarterly Diluted EPS Quarter Ending Diluted EPS YoY QoQ September … Read more
Quick Answer Longevity Health Holdings, Inc. reported Net Income of -$6.91 million for fiscal year 2025. Longevity Health Holdings, Inc. Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$6.91M +33.4% 2024 -$10.37M +32.9% 2023 -$15.45M -70.6% 2022 -$9.05M -2648.0% 2021 -$329.4K — Quarterly Net Income Quarter Ending Net Income YoY QoQ … Read more
Quick Answer Longevity Health Holdings, Inc. reported Revenue (ASC 606) of $1.91 million for fiscal year 2025. Longevity Health Holdings, Inc. Revenue (ASC 606) — Annual History Fiscal Year Revenue (ASC 606) YoY Change 2025 $1.91M +3701.4% 2024 $50.3K — 2023 $0.00 — Quarterly Revenue (ASC 606) Quarter Ending Revenue (ASC 606) YoY QoQ September … Read more